Enzalutamide trials for Prostatic Neoplasms, Castration-Resistant

All Enzalutamide trials · All Prostatic Neoplasms, Castration-Resistant trials

Phase breakdown

Recruiting trials studying Enzalutamide for Prostatic Neoplasms, Castration-Resistant

• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 160 locations
• Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
  NCT05393791 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 19 locations
• Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
  NCT05743621 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Enzalutamide for Prostatic Neoplasms, Castration-Resistant?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.